Live tape
Top 8, mentions 7d9,850TSLA2,037 mentions▲ +0.05GOOGL1,583 mentions▲ +0.04NVDA1,206 mentions▲ +0.07CRWV1,194 mentions▲ +0.03SPCX1,070 mentions▲ +0.07QQQ1,042 mentions▲ +0.04META873 mentions▲ +0.05NBIS845 mentions▲ +0.05

Equity · Healthcare

MDGL

NASDAQ

Madrigal Pharmaceuticals, Inc.

$514 +1.18% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Aug 5, 2026
Price · Chart
12 sessions
$600 $450 21 Jul 5 Aug

The line runs $547 on 21 July through $514 on 5 August, on a scale from $450 to $600. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView TradingView chart · our licensed closes: 12 sessions, 21 Jul – 5 Aug 2026
Market cap $11.9B
52-week range $289 – $604
Avg volume 117.0K

as of Aug 5, 2026

MDGL insider trades

SEC Form 4 · last 90 days · newest reported trade 11 Sep 2026
Open-market buys 0
Open-market sells 3
Net sold $6.58M
Non-trade filings 1
Date Insider Type Shares Value
11 Sep 2026 Sibold William John President and CEO Sell 5,221 $2.83M
09 Sep 2026 Sibold William John President and CEO Sell 6,362 $3.41M
17 Aug 2026 Kelley Shannon T General Counsel Sell 664 $342K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
15 Aug 2026 REED JOHN C Director Award 647

MDGL reported financials

SEC EDGAR XBRL SEC EDGAR

MDGL reported revenue of $958.4M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$288.3M.

Figure Reported Period
Revenue $958.4M 31 Dec 2025 fiscal year
Net income −$288.3M 31 Dec 2025 fiscal year
Diluted EPS −$10.15 31 Dec 2025 fiscal year
Total assets $1.2B 30 Jun 2026 at period end
Total equity $523.7M 30 Jun 2026 at period end

MDGL earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 −$1.99 —
31 Mar 2026 Q1 2026 −$3.25 —
31 Dec 2025 Q2 2026 −$10.15 —
30 Sep 2025 Q2 2026 −$4.01 —
30 Jun 2025 Q1 2026 −$1.50 —
31 Mar 2025 Q1 2025 −$2.61 $137M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

MDGL institutional holders

SEC Form 13F SEC EDGAR

11 of the 45 institutional funds we track reported a MDGL position for the quarter ended 30 Jun 2026 — a combined $1.7B; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Baker Bros. Advisors Held (±25%) +0.1% shares 2,143,131 $1.2B
Citadel Advisors Held (±25%) +11.8% shares 507,233 $272.4M
Point72 Asset Management Trimmed −39.2% shares 137,029 $73.6M
Marshall Wace Added +365.1% shares 101,859 $54.7M
Millennium Management Added +98.8% shares 81,196 $43.6M
Balyasny Asset Management New position 79,011 $42.4M
Renaissance Technologies Trimmed −36.1% shares 45,942 $24.7M
D. E. Shaw & Co. Held (±25%) +16.4% shares 35,071 $18.8M
AQR Capital Management Held (±25%) −0.8% shares 15,827 $8.5M
Tudor Investment Corp Held (±25%) −1.0% shares 11,509 $6.2M

Showing the 10 largest of 11 reported positions. The figures above count all of them.

MDGL fails-to-deliver

SEC CNS data SEC

On 15 Sep 2026, 3 shares of MDGL failed to deliver (about $2K).

Settlement date Shares failed Notional % of shares out
15 Sep 2026 3 $2K <0.001%

Congressional trades in MDGL

STOCK Act disclosures House disclosures

The most recent congressional trade disclosed in MDGL is a sale by Daniel S. Goldman (house, NY), dated 10 Apr 2023.

Date Member Type Amount
10 Apr 2023 filed 19 May 2023 Daniel S. Goldman house · Democrat–NY Sale $1K–$15K

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close), most closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. House disclosuresU.S. House of Representatives financial disclosures
  7. SEC EDGARValuation computed from SEC EDGAR filings